NCT04622540 EBD RCT Trial in Living Donor Liver Transplantation
| NCT ID | NCT04622540 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Hospital |
| Condition | Liver Transplantation |
| Study Type | INTERVENTIONAL |
| Enrollment | 124 participants |
| Start Date | 2020-12-09 |
| Primary Completion | 2024-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 124 participants in total. It began in 2020-12-09 with a primary completion date of 2024-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study was designed to demonstrate incidence of biliary complication rates after living donor liver transplantation according to the implantation of external biliary drainage throug duct-to-duct anastomosis site.
Eligibility Criteria
Inclusion Criteria: * Living donor liver transplantation * Adult patient (\>=18 years old) * Patients who are available for at least 3 year follow-up after LDLT Exclusion Criteria: * Patients requring hepaticojejunostomy due to anatomical factor or underlying disease * Re-transplantation * Multiorgan transplantation * Emergency transplantation
Contact & Investigator
Suk Kyun Hong, MD
STUDY CHAIR
Seoul National University Hospital
Frequently Asked Questions
Who can join the NCT04622540 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, up to 79 Years, studying Liver Transplantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04622540 currently recruiting?
Yes, NCT04622540 is actively recruiting participants. Contact the research team at sypurple@gmail.com for enrollment information.
Where is the NCT04622540 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT04622540 clinical trial?
NCT04622540 is sponsored by Seoul National University Hospital. The principal investigator is Suk Kyun Hong, MD at Seoul National University Hospital. The trial plans to enroll 124 participants.